Results for tag: "Egrifta"

Egrifta is a drug used to treat endocrine and metabolic disorders. It is a recombinant human growth hormone, which is used to reduce excess abdominal fat in HIV-infected adults with lipodystrophy. The drug works by stimulating the body to produce its own natural growth hormone, which helps to reduce fat in the abdomen and improve body composition. Egrifta is administered as a subcutaneous injection and is available in the form of a pre-filled syringe. The Egrifta market is composed of a variety of companies that manufacture and distribute the drug. These companies include Teva Pharmaceuticals, Mylan, and Sandoz, as well as specialty pharmaceutical companies such as ViiV Healthcare and Merck. Additionally, there are a number of generic manufacturers that produce generic versions of the drug. Show Less Read more